AutoLang vs Genomi

AutoLang and Genomi are both agent frameworks tracked by AIDiveForge. Below is a side-by-side comparison of pricing, capabilities, platforms, and ownership — sourced from each tool's live website and verified before publishing.

AutoLang

Orbit wraps each agent run in a bounded loop: it pulls one task from a dependency-ordered backlog, hands it to whatever agent you've wired up, runs tests, lint, and type checks, and refuses to close the task until validation passes. Every run produces structured JSON — what the agent returned, how it scored against a rubric, whether a human should accept or re-queue. That audit trail is the point. The ceiling appears when your workflow needs anything beyond task-level sequencing: parallel agent execution, real-time dashboards, or integration with existing CI pipelines requires you to build the glue yourself.

Genomi

The core workflow is four steps: install the agent harness, point it at your raw genome file on disk, build a local SQLite index, then ask questions through whichever AI agent you already run — Claude Code, Cursor, Gemini CLI, Goose, and others are listed as compatible. Pharmacogenomics, carrier status, polygenic risk scores, nutrigenomics, and ancestry PCA projection are all covered through distinct skill modules backed by ClinVar, PharmCAT, PGS Catalog, HPO, GenCC, and 1000 Genomes reference data. The privacy architecture is explicit: raw genome data stays on disk, and only the specific evidence snippets relevant to a query cross the boundary to whatever LLM handles the response. The vendor marks this as experimental and not for clinical use — which means researchers and privacy-conscious individuals exploring personal data are the intended audience, not clinical teams expecting diagnostic-grade output.

Attribute	AutoLang	Genomi
Pricing	Free	Free
Free trial	No	No
Open source	Yes	Yes
Has API	No	No
Self-hosted option	Yes	Yes
Platforms	Linux, macOS, Windows (Python)	Linux, macOS, Windows (Python-based)
Released	—	2024
Pros	Validation gates block task closure until tests, lint, and type checks pass, so regressions that would have silently shipped surface inside the orbit instead of in production. Agent-neutral adapter contract means you can swap Claude for Codex behind the same harness and compare structured evaluation artifacts, so agent selection becomes a decision based on evidence rather than anecdote. Dependency-aware backlog sequencing ensures each agent run starts from a task whose prerequisites are already verified, which means the cascading failures that come from running tasks out of order stop accumulating. Four structured artifacts per run — result, evaluation, review recommendation, progress log — give compliance or audit teams a complete evidence trail without requiring post-hoc reconstruction. MIT licensed and self-hosted, so sensitive codebases never leave your infrastructure and there is no vendor dependency on a paid tier to retain audit history.	Local-first data architecture keeps the raw genome file on disk and only sends queried evidence snippets to the LLM, so teams with strict data policies can explore personal genomic data without uploading a single variant to a third-party server. Skill modules cover pharmacogenomics via PharmCAT and ClinPGx, carrier status via ClinVar and HPO, polygenic risk via PGS Catalog, and ancestry via 1000 Genomes PCA — so a researcher doesn't have to stitch together five separate tools and manually reconcile their outputs. Each answer carries source attribution and stated evidence limits, which means you can trace a finding back to ClinVar or GenCC rather than accepting a response with no provenance — a real gap in generic LLM genomic Q&A. Agent-agnostic MCP and skills-host architecture plugs into whichever AI agent a team already runs, so there is no forced migration to a new interface or locked-in model provider. Apache-2.0 open-source license with self-hosted deployment means developers building agent-based genomic analysis tools can inspect, modify, and extend the skill layer without negotiating commercial terms.
Cons	Orbit executes one task per orbit, sequentially. Teams that need agents working in parallel on independent tasks hit this ceiling immediately — there is no built-in concurrency model, and adding it means maintaining a scheduling layer outside the harness. Integration with existing CI pipelines — GitHub Actions, Jenkins, or similar — is not provided. Teams that need orbit results to gate pull requests or trigger deployments write the integration themselves, which becomes a second system to maintain alongside Orbit. The evaluation rubric scores task focus, completion, diff signal, and validation, but the rubric definitions are fixed to what the harness ships with. Teams whose quality criteria don't map to those dimensions either accept scores that don't reflect their standards or fork the evaluation logic — at which point they own a modified harness diverging from upstream. When a team's workflow grows beyond single-repo, dependency-ordered task queues — multi-team backlogs, cross-service agents, or real-time progress visibility — Orbit's intentional smallness becomes a hard constraint. That's the condition under which teams move to a broader agent orchestration platform and treat Orbit's artifact schema as a reference rather than a production harness.	Installation requires following a source-code setup guide and configuring an AI agent to connect to the harness — non-technical users hit a wall before they ask a single question, and there is no hosted web interface to fall back on. The project is vendor-labeled experimental, which means skill coverage, reference database freshness, and edge-case handling are not production-guaranteed; teams relying on consistent outputs for any regulated or clinical-adjacent workflow will find the absence of validation documentation disqualifying and will move to a certified clinical genomics platform instead. There is no hosted API, so teams building products that need to serve genomic queries to end users must provision and maintain their own infrastructure — at scale, that maintenance burden is not accounted for in the zero-cost licensing. Evidence snippets sent to an external LLM during a query still cross a data boundary, even if the raw genome file stays local; teams operating under strict genomic data agreements need to verify that snippet-level transmission satisfies their compliance posture before deploying, and the tool provides no compliance documentation to support that review.

Bottom line

AutoLang and Genomi are closely matched on pricing model, openness, and API availability — pick by feature set and platform support in the table above.

Frequently asked questions

What is the difference between AutoLang and Genomi?

AutoLang is Free and open source, while Genomi is Free and open source. Compare pricing, free trial, API, platforms, and pros/cons in the table above on AIDiveForge.

Is AutoLang better than Genomi?

It depends on your workflow. Use the side-by-side attributes (pricing, open source, API, self-hosted, platforms) to decide. AIDiveForge does not rank a universal winner — we publish verified facts so you can choose.